Tobacco farmers, processors, and consumers in Kenya have been spared from an attempt to label their products as illegal, after a court dismissed a document questioning the legality of production, manufacturing, and use.
Ibrahim Mahmoud, a stakeholder in the world's leading tobacco company British American Tobacco (BAT), is hoping to force the government to ban the entire production, supply, management, promotion, consumption, and use of tobacco products and cigarettes through his involvement in a lawsuit as a interested party.
He also hopes to declare cancer as a disease related to tobacco and a national disaster that requires special governmental action, including allocating special budgets for consideration and prohibiting tobacco products.
However, Judge Hedwig Ong'udi dismissed the application on the grounds that the petitioner failed to prove that the Tobacco Control Act and the 2014 Tobacco Control Regulations violated the legal provisions he had alleged.
Therefore, simply relying on his dissatisfaction with the use and legalization of tobacco products in Kenya is not enough. He should use evidence to prove how regulations and laws have violated the legal provisions he is complaining about," the judge said.
British American Tobacco is one of the companies with the highest dividends on the Nairobi Securities Exchange. The company has stated that this document threatens its right to conduct legitimate business.
This is because the petitioner is seeking the complete restriction of the manufacture and sale of tobacco products. Granting the petition would violate the legitimate expectation rights of the company to engage in commercial activities," said British American Tobacco.
The company stated that the right to ban tobacco products belongs to the parliament rather than the court, and believes that overturning it would result in illegal and dangerous cigarettes.
British American Tobacco's half-year profit in Kenya increased by 8.4% to KES 2.9 billion.
2FIRSTS will continue to provide coverage on this topic. Further updates will be available on the "2FIRSTS APP". Scan the QR code below to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
